RPE mosaic imaged for the first time in a living retina

Article

The retinal pigment epithelial (RPE) cell mosaic has been imaged for the first time in a living retina using an adaptive optics scanning laser ophthalmoscope (AOSLO), according to a report published in the March issue of Investigative Ophthalmology & Visual Science.

The retinal pigment epithelial (RPE) cell mosaic has been imaged for the first time in a living retina using an adaptive optics scanning laser ophthalmoscope (AOSLO), according to a report published in the March issue of Investigative Ophthalmology & Visual Science.

David Williams and colleagues from the University of Rochester, Center for Visual Science, New York conducted a study in which the retina was imaged simultaneously with two light channels in a fluorescence AOSLO. One channel was used for reflectance imaging of the cones while the other detected RPE autofluorescence. Reflectance frames were registered to determine interframe eye motion, the motion was corrected in the simultaneously recorded autofluorescence frames (AFs) and the AFs were averaged to give the final mosaic image.

In vivo imaging showed that, with increasing eccentricity, RPE cell density and mosaic regularity decreased, whereas RPE cell size and spacing increased. Measurements of the same location where repeated after 42 days and it was discovered that neither the cells or distribution of cells had changed.

The authors of the study concluded that mosaic analysis can provide a quantitative database for studying normal and diseased PRE in vivo. Furthermore, the technique will allow studies to track disease progression and assess treatment efficacy in patients with retinal disease.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.